Pfizer
American multinational pharmaceutical and biotechnology corporation / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Pfizer?
Summarize this article for a 10 year old
Company type | Public |
---|---|
Industry | |
Founded | 1849; 175 years ago (1849) in New York City |
Founders | |
Headquarters | The Spiral, New York City , U.S. |
Area served | Worldwide |
Key people | Albert Bourla (CEO) |
Products | |
Revenue | US$58.5 billion (2023) |
US$2.17 billion (2023) | |
US$2.12 billion (2023) | |
Total assets | US$226.5 billion (2023) |
Total equity | US$89.01 billion (2023) |
Number of employees | c. 88,000 (2023) |
Website | pfizer |
Footnotes / references [1][2] |
Pfizer Inc. (/ˈfaɪzər/ FY-zər)[3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues).[1] In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.[1]
The company ranks 38th on the Fortune 500[4] and 39th on the Forbes Global 2000.[5]